IONIS PHARMACEUT reported $-105135000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -277.4M 37.06M
Arrowhead Research ARWR:US $ -72046000 116.41M
Astellas Pharma 4503:JP Y 24812M 33220M
Biocryst Pharmaceuticals BCRX:US $ -58.86M 15.34M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Exelixis EXEL:US $ 70.67M 2.1M
Halozyme Therapeutics HALO:US $ 22.68M 37.42M
Intercept Pharmaceuticals ICPT:US $ -7.53M 9.76M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Moderna Inc MRNA:US 2.2B 1.46B
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Novartis NOVN:VX SF 1694M 528M
Omeros OMER:US $ -30849000 2.16M
Pfizer PFE:US $ 9905M 2042M
Ptc Therapeutics PTCT:US $ -152.09M 25.36M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Sarepta Therapeutics SRPT:US $ -231.48M 126.46M
Ultragenyx Pharmaceutical RARE:US $ -158.16M 5.84M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M